Annual Accounts Receivable
N/A
December 31, 2023
Summary
- APVO annual accounts receivable is not available.
Performance
APVO Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Accounts Receivable
N/A
September 30, 2024
Summary
- APVO quarterly accounts receivable is not available.
Performance
APVO Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
APVO Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | - | - |
| 5 y5 years | - | - |
APVO Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time |
Aptevo Therapeutics Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2019 | - | $7.92 M(+7.3%) |
| Jun 2019 | - | $7.38 M(+27.2%) |
| Mar 2019 | - | $5.80 M(+11.1%) |
| Dec 2018 | $5.22 M(+143.8%) | $5.22 M(-15.8%) |
| Sep 2018 | - | $6.20 M(+0.9%) |
| Jun 2018 | - | $6.14 M(+98.4%) |
| Mar 2018 | - | $3.10 M(+44.7%) |
| Dec 2017 | $2.14 M | $2.14 M(+305.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2017 | - | $528.00 K(-88.8%) |
| Jun 2017 | - | $4.71 M(+144.8%) |
| Mar 2017 | - | $1.93 M(+527.4%) |
| Dec 2016 | $307.00 K(-95.2%) | $307.00 K(-89.6%) |
| Sep 2016 | - | $2.96 M(-65.3%) |
| Jun 2016 | - | $8.51 M(+146.2%) |
| Mar 2016 | - | $3.46 M(-46.4%) |
| Dec 2015 | $6.46 M(-53.3%) | $6.46 M |
| Dec 2014 | $13.82 M | - |
FAQ
- What is the all time high annual accounts receivable for Aptevo Therapeutics?
- What is the all time high quarterly accounts receivable for Aptevo Therapeutics?
What is the all time high annual accounts receivable for Aptevo Therapeutics?
Aptevo Therapeutics all-time high annual accounts receivable is $13.82 M
What is the all time high quarterly accounts receivable for Aptevo Therapeutics?
Aptevo Therapeutics all-time high quarterly accounts receivable is $8.51 M